Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Nature Communications|August 26, 2022
DAXX-ATRX regulation of p53 chromatin binding and DNA damage responseNitish Gulve, Chenhe Su, Zhong Deng, et al.
Molecular Cell|December 13, 2005
MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma proteinPatima Sdek, Haoqiang Ying, Donny L F Chang, et al.
International Journal of Oncology|September 6, 2019
Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathwayNaiyan Wen, Baofeng Guo, Hongwu Zheng, et al.
Stem Cell Reports|April 3, 2018
Far Upstream Element-Binding Protein 1 Regulates LSD1 Alternative Splicing to Promote Terminal Differentiation of Neural ProgenitorsInah Hwang, Dongqing Cao, Yoonmi Na, et al.
Molecular Cancer Therapeutics|October 1, 2020
A Combination of BRD4 and HDAC3 Inhibitors Synergistically Suppresses Glioma Stem Cell Growth by Blocking GLI1/IL6/STAT3 Signaling AxisQian Wang, Shengnan Jia, Ding Wang, et al.
Nature|October 25, 2002
The prolyl isomerase Pin1 is a regulator of p53 in genotoxic responseHongwu Zheng, Han You, Xiao Zhen Zhou, et al.
Biochemical Pharmacology|June 26, 2020
RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7Hang Liang, Qian Wang, Ding Wang, et al.
Cancer Discovery|June 19, 2013
ZNF365 promotes stability of fragile sites and telomeresYuqing Zhang, Sandra J Shin, Debra Liu, et al.
Cancer Research|January 29, 2021
Therapy-Induced Transdifferentiation Promotes Glioma Growth Independent of EGFR SignalingHwanhee Oh, Inah Hwang, Ja-Young Jang, et al.
Cancer Research|March 27, 2015
Development of Resistance to EGFR-Targeted Therapy in Malignant Glioma Can Occur through EGFR-Dependent and -Independent MechanismsStefan Klingler, Baofeng Guo, Jun Yao, et al.
Pageof 5